NovaBridge Biosciences Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

170.00M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	632.00K	2.18M	-
Dec 31, 2022	-1.55M	-15.40M	-
Dec 31, 2021	13.85M	-222.30M	-94.14%
Dec 31, 2020	236.15M	231.84M	5,381.19%
Dec 31, 2019	4.31M	-3.51M	-44.90%
Dec 31, 2018	7.82M	6.04M	340.20%
Dec 31, 2017	1.78M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Protalix BioTherapeutics	76.38M
Spero Therapeutics	61.19M
Alector	18.42M
Innate Pharma	10.57M
Equillium	4.39M
Korro Bio	3.84M
Milestone Pharmaceuticals	1.78M

Revenue Rankings

NBP News

2 hours ago - NovaBridge Biosciences Receives FDA Fast Track Designation for Givastomig in First-Line HER2-Negative Metastatic Gastric Cancer - GlobeNewsWire
11 days ago - NovaBridge Biosciences Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
19 days ago - NovaBridge to Present at the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
27 days ago - NovaBridge Biosciences Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
5 weeks ago - NovaBridge to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference - GlobeNewsWire
7 weeks ago - NovaBridge Appoints Mark Hagler as President and Chief Commercial Officer to Advance Commercial Strategy and Maximize Pipeline Value - GlobeNewsWire
2 months ago - NovaBridge Biosciences Slides: Company presentation - Filings
2 months ago - NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire

More News